Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the early diagnosis of hepatocellular carcinoma
Weiyi Wang, Chao Wei
Genes & Diseases (2020) Vol. 7, Iss. 3, pp. 308-319
Open Access | Times Cited: 343

Showing 1-25 of 343 citing articles:

Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib
Chen Yang, Tao Lu, Ming Liu, et al.
Phytomedicine (2023) Vol. 111, pp. 154668-154668
Closed Access | Times Cited: 53
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 29
An RNA–RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity
Yanping Wei, Xuewu Tang, Yibin Ren, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 75
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 32
Unveiling the Mystery of SUMO-activating enzyme subunit 1: A Groundbreaking Biomarker in the Early Detection and Advancement of Hepatocellular Carcinoma
Haojun Wang, Tongwang Yang, Jiyue Wu, et al.
Transplantation Proceedings (2023) Vol. 55, Iss. 4, pp. 945-951
Closed Access | Times Cited: 28
Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
Mona A. Omar, Mohamed M. Omran, Khaled Farid, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1852-1852
Open Access | Times Cited: 27
The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets
Ziwei Tang, Xue Li, Yanfeng Zheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 15
Diverse interactions between AIEgens and biomolecules/organisms: Advancing from strategic design to precision theranostics
Qihang Ding, Xiaoyu Xu, Yang Li, et al.
Chem (2024) Vol. 10, Iss. 7, pp. 2031-2073
Closed Access | Times Cited: 14
Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma
Jiazhou Ye, Xing Gao, Xi huang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 8
Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis
Tianyi Huang, Jing Chen, Pengfei Zhang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
A split-type near-infrared photoelectrochemical and colorimetric dual-mode biosensor for the high-performance determination of HepG2 cells
Yawen Hong, Lian Xu, Hengwei Sun, et al.
Talanta (2025) Vol. 287, pp. 127622-127622
Closed Access | Times Cited: 1
Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies
Tian Yang, Yu-Sheng Shi
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 02, pp. 369-384
Open Access | Times Cited: 1
Application of Indirect ELISA and PCR Techniques for Detecting of Hepatocellular Carcinoma using Des-gamma Carboxyprothrombin, Alpha-fetoprotein, and Thioredoxin Biomarkers
Huy Quang Duong, Nguyen Xuan Khai, Tran Hong Thinh, et al.
Molecular Biotechnology (2025)
Closed Access | Times Cited: 1
Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Methyltransferase-Like 3-Mediated m6A Methylation of Hsa_circ_0058493 Accelerates Hepatocellular Carcinoma Progression by Binding to YTH Domain-Containing Protein 1
Anqi Wu, Yuhao Hu, Yao Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 45
Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti‐PD‐1 based immunotherapy in hepatocellular carcinoma
Hewei Wu, Xingrong Zheng, Tao Pan, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 8, pp. 1321-1334
Closed Access | Times Cited: 30
Interventional nanotheranostics in hepatocellular carcinoma
Vivek P. Chavda, Pankti C. Balar, Srushti B. Patel
Nanotheranostics (2023) Vol. 7, Iss. 2, pp. 128-141
Open Access | Times Cited: 18
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies
Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 18
Circulating miRNA’s biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms
Gehad Ismail Sayed, Mona Solyman, Gamalat El Gedawy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Hepatocellular carcinoma biomarkers screening based on hydrogel photonic barcodes with tyramine deposition amplified ELISA
Wenjing Xue, Li Wang, Kexin Yi, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116270-116270
Closed Access | Times Cited: 7
Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019
Omar Al Ta’ani, Yazan A. Al‐Ajlouni, Balaji Jagdish, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis
Qianwei Zhao, Mengdan Yu, Jinxia Li, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma
Xuejing Wang, Xiaojun Wang
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma
Yamei Huang, Min Peng, Weiping Yu, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112534-112534
Closed Access | Times Cited: 6
Tumor Cell-Derived Exosomal Circ-0072088 Suppresses Migration and Invasion of Hepatic Carcinoma Cells Through Regulating MMP-16
Ye Lin, Zehao Zheng, Jianxi Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top